Press release
Isothermal Nucleic Acid Amplification Technology Market in 2024
"Isothermal Nucleic Acid Amplification Technology Market" in terms of revenue was estimated to be worth $4.53 billion in 2023 and is poised to reach $8.91 billion by 2031, growing at a CAGR of 8.9% from 2024 to 2031 according to a new report by InsightAce Analytic.Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2001
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global isothermal nucleic acid amplification technology market is:
• Technological advancement
• Rising interest in tailored healthcare
• Development in the fields of biology and pharmaceuticals
The following are the primary obstacles to the isothermal nucleic acid amplification technology market's expansion:
• High costs
• Shortage of competent experts
• Rules and regulations
Future expansion opportunities for the global isothermal nucleic acid amplification technology market include:
• Improving healthcare facilities
• Growth in research and development
• Increasing incomes per capita
• The regulatory structure that controls the creation and utilization of INAAT-based diagnostic and therapeutic techniques is a big roadblock limiting the market's development.
Market Analysis:
The rising prevalence of infectious diseases has led to a dramatic increase in the demand for this technology as a molecular testing tool. Tuberculosis, hepatitis, and influenza are among the most prevalent infectious diseases that cause mortality, particularly in developing countries. The need for easy, fast, and disease-specific testing options will likely drive the demand for solutions utilizing isothermal nucleic acid amplification technology (INAAT).
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
List of Prominent Players in the Isothermal Nucleic Acid Amplification Technology Market:
• Grifols, S.A. (Spain),
• Hologic, Inc. (US),
• Abbott Laboratories (US),
• Becton, Dickinson and Company (US),
• Meridian Bioscience (US),
• Eiken Chemical Co., Ltd. (Japan),
• bioMérieux SA (France),
• Tecan Trading AG (Switzerland),
• New England Biolabs (US),
• QIAGEN N.V. (Germany),
• DiaSorin Sp.A. (Italy),
• General Electric (US),
• OptiGene Limited (UK),
• Quidel Corporation (US),
• Thermo Fisher Scientific (US).
• Genomtec (Poland),
• Mast Group Ltd. (UK),
• Ustar Biotechnologies (China),
• Jena Bioscience GmbH (Germany),
• Atila BioSystems (US),
• TwistDx Limited (UK),
• LGC Limited (UK),
• Life Sciences Advanced Technologies (US),
• GenoSensor Corporation (US),
• PCR Biosystems (UK)
Recent Developments:
• In March 2024, BD (Becton, Dickinson, and Company) announced the enrollment of the first patient in AGILITY. This IDE study will evaluate the efficacy and safety of the BD cardiovascular Included Artery for managing peripheral artery disease (PAD).
• In March 2024, Thermo Fisher Scientific Inc. announced opening a new CorEvitas syndicated clinical registry for generalized pustular psoriasis (GPP). Enrollment in this registry is currently available. It is CorEvitas' tenth syndicated illness registry. It closes a gap in the research by offering real-world data (RWE) about the clinical and medical results of individuals with GPP.
• In February 2024, GE Vernova introduced GridBeats, a comprehensive software-defined automation solution designed to improve grid resilience and streamline digitalization.
Isothermal Nucleic Acid Amplification Technology Market Dynamics:
Market Drivers: Technological Advancement
Isothermal nucleic acid amplification technology is seeing a surge in demand as consumers seek more intuitive, rapid, and disease-specific diagnostic tools. The isothermal nucleic acid amplification technology market is expected to rise in the next years due to rising disposable income and improved healthcare infrastructure in emerging nations. The demand for affordable pharmaceuticals and treatments for genetic illnesses has surged due to the development of a gene-based drug in response to the increasing number of infectious diseases. Another major growth driver of the isothermal nucleic acid amplification technology market is the shrinking of nucleic-acid diagnostics.
Challenges: Rules And Regulations
The utilization of point-of-care applications for amplification techniques, like PCR, is hindered by the requirement of instrumentation capable of thermal cycling and temperature control. Regulating the development of diagnostics based on INAAT is a major obstacle to the industry's growth. In addition, Patients' lack of knowledge and unclear regulations on INAAT-based diagnostics limit the promotion of INAAT solutions.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2001
North America is Expected to Grow with the Highest CAGR During the Forecast Period
The North America isothermal nucleic acid amplification technology market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because state-of-the-art healthcare systems and technologies are being widely used. Also, the product is in demand due to cost-effective detection and growing worries about infectious diseases in the elderly, which will likely continue to fuel demand during the projection period.
Segmentation of Isothermal Nucleic Acid Amplification
Technology Market-
By Product-
• Assays, Kits & Reagents
• Systems
By Technology-
• Transcription Mediated Amplification (TMA)
• Loop-mediated Isothermal Amplification (LAMP)
• Strand Displacement Amplification (SDA)
• Helicase-dependent Amplification (HDA)
• Nucleic Acid Sequence-based Amplification (NASBA)
• Nicking Enzyme Amplification Reaction (NEAR)
• Single Primer Isothermal Amplification (SPIA)
• Other Technologies
By Application-
• Disease Diagnosis
o Hepatitis
o Chlamydia trachomatis (CT)
o Neisseria gonorrhoeae (NG)
o Influenza
o Covid-19
o Other Disease Diagnosis
• Blood Screening
• Other Applications
By End-User-
• Hospitals
• Reference Laboratories
• Academic & Research Laboratories
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2001
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Isothermal Nucleic Acid Amplification Technology Market in 2024 here
News-ID: 3798841 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.

Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…

Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…

Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…

Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Amplification
Guest Post: Rolling Circle Amplification Market
Introduction
Rolling Circle Amplification (RCA) is a highly efficient and versatile DNA amplification technique that has gained significant attention in recent years for its potential applications in biotechnology, molecular biology, diagnostics, and nanotechnology. Unlike traditional PCR (Polymerase Chain Reaction), RCA amplifies circular DNA templates through a process where a DNA polymerase synthesizes a long strand of DNA by continuously rolling around the template. This method produces multiple copies of the target…
Rolling Circle Amplification Market: Insights and Trends
Rolling Circle Amplification (RCA) is a novel DNA amplification technique that has gained significant attention in recent years. It is a versatile and efficient method for amplifying circular DNA sequences, and it has found applications in various fields, including molecular diagnostics, biotechnology, and medical research. RCA involves the use of a short DNA primer to initiate the synthesis of long single-stranded DNA products by rolling circle replication. This technique is…
Gene Amplification Technologies Market Size Report 2028
From 2021 to 2028, the global Gene Amplification Technologies Market is predicted to grow at a CAGR of 8.6%, from US$ 26,489 Million in 2020 to US$ 50,636 Million by 2028.
The global gene amplification technologies market is expected to exhibit strong growth during the forecast period, driven by the rising demand for COVID-19 testing and cancer research. This analysis provides comprehensive insights into market size, trends, drivers, challenges, regional outlook,…
Gene Amplification Technologies Market Report 2028
The Gene Amplification Technologies Market Research Report provides an in-depth analysis of the market dynamics, key players, and competitive landscape of the Gene Amplification Technologies industry. It aims to provide valuable insights into the market trends, growth opportunities, and challenges faced by the industry stakeholders. The report serves as a comprehensive guide for businesses and investors looking to make informed decisions in the Gene Amplification Technologies business.
The Gene Amplification Technologies…
Gene Amplification Technologies Market Size, CAGR | Growth - 2028
According to Ameco Research, the worldwide market for gene amplification technologies will increase at a CAGR of more than 8% throughout the forecast period, reaching a market size of more than US$ 50,630 million by 2028.
According to the World Cancer Research Fund, the worldwide toll of cancer cases was more than 18 million in 2020. Out of these, more than 9 million cases were in men and more than…
Whole Genome Amplification Market Investment Analysis
The whole genome amplification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.90% in the forecast period of 2021 to 2028 and is expected to reach USD 4,492.52 million by 2028. The high application of the method in the various fields of the biological fields is escalating the growth…